Enhance your practice with CME and tools that focus on the management of neurological conditions.
FXIa Remix! Keeping the Flow Without Missing a Beat
Mike Sharma, MD, MSc, FRCPC
Ashkan Shoamanesh, MD
Brian Mac Grory, MB, BCh BAO, MRCP, FAHA, FANA
Understanding Variability in Myasthenia Gravis
Henry Kaminski, MD
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
Prem S. Subramanian, MD, PhD
Andrew G. Lee, MD
Valerie Biousse, MD
Examining the Global Genetic Prevalence of TK2d
Brian P. McDonough, MD, FAAFP
Austin Larson, MD
Amyloid-β Therapies in Practice: Not All Are Created Equal
Dani Cabral, MD
Mohammed Q. Al-Sabbagh, MD
Beyond Cognition: Managing Alzheimer’s as an Integrated Neurodegenerative–Neuropsychiatric Syndrome
Marwan Sabbagh, MD, FAAN
NPS Psychosis: Circuits, Treatment, and New Hope
Advancing Acromegaly Care: Diving Deeper Into Diagnosis, Guideline Application, and Emerging Therapies—A Fireside Chat With Expert Perspectives
June 15, 2026
07:30 AM - 09:00 AM ET
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic AD
June 03, 2026
06:00 PM - 07:00 PM CEST
Tau Therapies and Clinical Translation: Mechanistic Approaches
Unseen Impact of NPS in AD: Domains and Burden
Chicago, Illinois
June 15, 2026 Chicago, Illinois
Microglia Drive Neurodegeneration in Friedreich’s Ataxia
Ryan Quigley
Unpacking the Genetics of Friedreich’s Ataxia
Arnulf Koeppen, MD
Friedreich’s Ataxia: Impact of Frataxin Loss
Rethinking Secondary Stroke Prevention: The Emerging Role of Factor XI Inhibition
Mukul Sharma, MD, MSc, FRCPC
Ashkan Shoamanesh, MD, MSc, FRCPC
Neuroinflammation to Network Instability: Translating FAAH/MAGL Biology to NPS
NPS Agitation: Evidence and Emerging Mechanisms of Management
Is Friedreich’s Ataxia Developmental or Degenerative?
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.